Article info
PDFEditorial
Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses
- Correspondence to Dr Yvan J-F Hutin, Global Hepatitis Programme, World Health Organization, Avenue Appia, 20, Geneva 1211, Switzerland; hutiny{at}who.int
Citation
Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses
Publication history
- Received July 12, 2016
- Revised August 3, 2016
- Accepted August 4, 2016
- First published August 26, 2016.
Online issue publication
April 25, 2019
Article Versions
- Previous version (10 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/